<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p251.xml</sm:loc><ifp:title>Putting Precision Medicine on the National Agenda</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p251.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Putting Precision Medicine on the National Agenda</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-pxx.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-pxx.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-pxlix.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-pxlix.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p261.xml</sm:loc><ifp:title>Myelodysplastic Syndromes, Version 2.2015</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p261.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Myelodysplastic Syndromes, Version 2.2015</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p252.xml</sm:loc><ifp:title>Evaluating the Potential Role of PET/CT in the Posttreatment Surveillance of Head and Neck Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p252.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Evaluating the Potential Role of PET/CT in the Posttreatment Surveillance of Head and Neck Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p255.xml</sm:loc><ifp:title>NCCN: Evolution in the Early Years</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p255.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN: Evolution in the Early Years</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p288.xml</sm:loc><ifp:title>Abiraterone in Metastatic Salivary Duct Carcinoma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p288.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Abiraterone in Metastatic Salivary Duct Carcinoma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p281.xml</sm:loc><ifp:title>Leukemic Diffuse Large B-Cell Lymphoma in a Patient With Myeloproliferative Disorder</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p281.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Leukemic Diffuse Large B-Cell Lymphoma in a Patient With Myeloproliferative Disorder</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p311.xml</sm:loc><ifp:title>Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p311.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p303.xml</sm:loc><ifp:title>Association Between Urologist Characteristics and Radiation Oncologist Consultation for Patients With Locoregional Prostate Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p303.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Association Between Urologist Characteristics and Radiation Oncologist Consultation for Patients With Locoregional Prostate Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p319.xml</sm:loc><ifp:title>Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p319.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p297.xml</sm:loc><ifp:title>Health Behaviors and Quality of Life Among Colorectal Cancer Survivors</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p297.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Health Behaviors and Quality of Life Among Colorectal Cancer Survivors</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p326.xml</sm:loc><ifp:title>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p326.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p371.xml</sm:loc><ifp:title>Mimicking MacGyver in the Oncology Clinic: Improvisation and Creative Solutions, Only Rarely Involving Duct Tape</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p371.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Mimicking MacGyver in the Oncology Clinic: Improvisation and Creative Solutions, Only Rarely Involving Duct Tape</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p363.xml</sm:loc><ifp:title>Is Observation Dead in Follicular Lymphoma? No, But the Apoptosis Pathway Has Been Activated</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p363.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Is Observation Dead in Follicular Lymphoma? No, But the Apoptosis Pathway Has Been Activated</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p367.xml</sm:loc><ifp:title>Is Observation Dead in Follicular Lymphoma? Still Appropriate</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/3/article-p367.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Is Observation Dead in Follicular Lymphoma? Still Appropriate</ifp:title></sm:url></urlset>
